Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 676-700 of 834 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
To Compare the effects of post isometric relaxation and strain-counterstrain technique on pain, Range of motion and functional activities among individuals with gastrocnemius tightness.
Design:
Single blinded randomized clinical trial with parallel assignment of 44 participants to two groups equally.
Settings and conduct:
The study will be conducted at Arif Memorial Teaching Hospital. Outcome assessor will be kept blind.
Participants/Inclusion and exclusion criteria:
Inclusion Criteria:
Participants from age group of 18-40 who present with gastrocnemius tightness.
Patients with positive silfverskiold test.
Exclusion Criteria:
Systemic disease causing musculoskeletal issue.
Any other type of connection tissue disorder.
With history of neurological disorder.
Having recent lower limb or spine fracture causing change in gait pattern.
Intervention groups:
Group A: Participants of group A received exercise post isometric relaxation exercise, 3 times a week for 4 weeks.
Group B: Participants of group B received strain-counterstain technique, 3 times a week for 4 weeks.
Main outcome variables:
Pain: The intensity of pain will be measured by the numeric pain rating scale [NPRS].
Range of motion: ROM will be measured using a Universal Goniometer.
Functional activities: Functional activities will be examined by foot functional index.
Study aim:
To compare the opioid-sparing effect of intraoperative intravenous ibuprofen versus placebo in patients undergoing laparoscopic cholecystectomy, in terms of postoperative opioid consumption, pain scores, and requirement for rescue analgesia.
Design:
A single-center, randomized, placebo-controlled, parallel-group trial with blinded outcome assessment involving 60 patients (30 in each group).
Settings and conduct:
The study will be conducted in the Department of Anesthesia, National Hospital & Medical Center Lahore. Patients will be randomized into two groups by using the closed envelope method: the ibuprofen group (n = 30) and the control group (n = 30). The randomization will be blinded to all assessors
Participants/Inclusion and exclusion criteria:
Inclusion Criteria
Age 18–65 years
ASA physical status I–II
Patients scheduled for laparoscopic cholecystectomy
Exclusion Criteria
Chronic use of NSAIDs or opioids
Intraoperative discontinuation of study protocol for any reason
Known contraindication or hypersensitivity to study drugs (ibuprofen/tramadol)
Intervention groups:
Intervention Group 1:
The ibuprofen group (n = 30) will receive 400 mg (100 ml) of intravenous ibuprofen over 20 minutes, 20 minutes before extubation.
Control Group:
The control group (n = 30) will receive 100 ml of normal saline intravenously over 20 minutes, 20 minutes before extubation.
Main outcome variables:
Total postoperative opioid consumption (tramadol dose in mg) within 24 hours after laparoscopic cholecystectomy. Postoperative pain scores using Visual Analogue Scale (VAS) at 2-hour intervals for up to 12 hours. Time to first rescue analgesia. Requirement for rescue analgesia (yes/no). Total dose of rescue analgesia administered.
Study aim:
This study was designed to compare the outcomes of SPG block administered via transmucosal and transcoronoid approaches in patients with autonomic cephalalgia
Design:
prospective quasi-experimental comparative study
Settings and conduct:
Department of Pain Medicine, CMH Rawalpindi over a period of six months
Participants/Inclusion and exclusion criteria:
Inclusion Criteria
Patients aged 18–65 years with a clinical diagnosis of trigeminal autonomic cephalalgia were included. Eligible participants were those with inadequate response to at least six months of standard oral pharmacotherapy (including amitriptyline, duloxetine, venlafaxine, pregabalin or gabapentin) and who reported moderate to severe pain intensity (defined as a Numeric Rating Scale - NRS score greater than 6). Only patients without evidence of secondary headache disorders or underlying dental or palatal pathology were enrolled.
Exclusion Criteria
Individuals with identifiable dental or palatal abnormalities contributing to facial pain, patients with secondary headache etiologies such as intracranial tumors or hemorrhage, patients with structural abnormalities including cleft lip/ palate or nasal septal defects, history of trauma or surgical intervention, patients with significant coagulopathy, hepatic or renal dysfunction, as well as those with a history of malignancy, were excluded from the study.
Intervention groups:
Group A underwent sphenopalatine ganglion (SPG) block via the transmucosal approach, whereas Group B received the block through fluoroscopy guided transcoronoid approach.
Main outcome variables:
The primary outcome was the mean change in NRS score from baseline to one month.
Study aim:
To compare knowledge outcomes following chatbot-facilitated case-based learning and
traditional facilitator-led case-based learning among undergraduate dental students.
Design:
A single-center concealed, randomized, crossover trial conducted among third-year Bachelor of Dental Surgery (BDS) students between December 2025 and January 2026. Because of the nature of the educational intervention, participants and facilitators were not blinded. A total of 32 students participated in Session 1 and 27 students participated in Session 2.
Settings and conduct:
Foundation University College of Dentistry, Foundation University Islamabad.
Participants/Inclusion and exclusion criteria:
Participants
3rd Year Bachelor of Dental Surgery (BDS) students.
Inclusion Criteria
Third-year BDS students.
Enrolled in the Oral Pathology course.
Able to understand English.
Provided written informed consent.
Willing to participate in both study sessions.
Exclusion Criteria
Declined participation.
Withdrew consent.
Absent during either study session or the corresponding assessments.
Intervention groups:
Intervention
Students participated in chatbot-facilitated case-based learning using a customized GPT-based
educational chatbot. Participants were stratified based on their most recent Oral Pathology examination
scores and randomized in a 1:1 ratio into two sequences: Sequence 1: Traditional CBL → Chatbot-CBL
Sequence 2: Chatbot-CBL → Traditional CBL. The study followed a crossover design in which students participated in two CBL sessions conducted two weeks apart to minimize potential carryover effects (Session 1: Soft Tissue Pathology; Session 2: Salivary Gland Pathology).
Control Group
In both sequences, the traditional CBL served as control group.
Main outcome variables:
Knowledge outcomes of traditional vs chat-bot CBL.
Study aim:
To compare the antihypertensive efficacy of valsartan and Telmisartan in young adults with newly diagnosed essential hypertension by assessing changes in systolic and diastolic blood pressure after 12 weeks of treatment.
Design:
Single-center, two-arm, parallel-group, randomized controlled superiority trial enrolling 126 participants. Participants will be randomly allocated in a 1:1 ratio to receive valsartan or Telmisartan for 12 weeks.
Settings and conduct:
This study will be conducted at the Department of Medicine, CMH Rawalpindi. Eligible participants will be randomized to receive Valsartan or Telmisartan and followed for 12 weeks with standardized blood pressure assessments.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Adults aged 18–40 years with newly diagnosed essential hypertension who provide informed consent. Exclusion criteria: Secondary hypertension, pregnancy or lactation, severe renal or hepatic disease, hypersensitivity to ARBs, or serious comorbid illness.
Intervention groups:
Participants will receive valsartan 160 mg orally once daily for 12 weeks, along with standard lifestyle modification advice. Blood pressure will be measured at baseline and scheduled follow-up visits.
Main outcome variables:
Primary outcome: Change in systolic and diastolic blood pressure (mmHg) from baseline to 12 weeks. Secondary outcome: Proportion of participants achieving target blood pressure (<140/90 mmHg) at 12 weeks.
Study aim:
The aim of this study is to evaluate the lipid profile level changes assessed by total serum cholesterol (TC), serum low density lipoproteins (LDLs), serum triglycerides (TGs) and serum high density lipoproteins
(HDLs) after six months of levothyroxine therapy in patients with presenting with sub-clinical hypothyroidism.
Design:
Pragmatic research, quasi experimental study, carried out at the Department of Medicine, Combined Military Hospital, Hyderabad from August 2025 – January 2026
Settings and conduct:
After approval from the Institutional Ethical Review Committee, CMH Hyderabad, the study was conducted in the institute, ensuring strict confidentiality and data protection according to institutional and international guidelines. Simple random sampling was used to recruit a total of 90 adult patients aged 18–65 years diagnosed with mild SCH (sub-clinical hypothyroidism) (TSH 4.49–10 mIU/L) or moderate SCH (TSH >10 mIU/L) with normal T3 and T4 levels. They were screened through laboratory-verified thyroid profiles.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: all patients aged 18-65 years of age diagnosed with sub-clinical hypothyroidism (mild and moderate) as per the WHO definition criteria furnished in the methodology and planned for levothyroxine therapy for six months.
Exclusion criteria: patients already on thyroid replacement therapy, Overt hypothyroidism or Hyperthyroidism, Pregnancy or lactation, use of medications significantly known to affect thyroid function or lipid metabolism ( e.g amiodarone, statins)
Intervention groups:
All patients received the same levothyroxine regimen of 1.6 mcg/kg/day.
Main outcome variables:
Primary variables studied were mean change in serum lipid levels assessed by total serum
cholesterol, serum low density lipoproteins, serum triglycerides and serum high density lipoproteins.
Study aim:
To compare the outcomes of intranasal versus intravenous dexmedetomidine for procedural sedation in pediatric patients undergoing MRI.
Design:
Non Randomized Control Trial
Settings and conduct:
Setting: Department of Radiology and Imaging
Conduct: Data will be collected prospectively after approval of the synopsis, from eligible children aged 1 month–12 years requiring MRI under sedation, following pre-anesthesia assessment and written informed consent. Participants will be consecutively allocated by alternate assignment into Group A (intranasal dexmedetomidine, n=63) and Group B (intravenous dexmedetomidine, n=63). Standard monitoring will be applied, and sedation depth will be assessed every 5 minutes using the University of Michigan Sedation Scale (UMSS), with MRI initiated once UMSS ≥2 is achieved. Sedation onset time, duration, physiological parameters, rescue sedation requirements, and adverse events will be recorded. Failure to achieve adequate sedation within 20 minutes or significant movement during MRI requiring rescue sedation will be considered primary sedation failure
Participants/Inclusion and exclusion criteria:
INCLUSION CRITERIA: Children aged 1 month to 12 years scheduled for elective MRI. American Society of Anesthesiologists (ASA) physical status I and II.
EXCLUSION CRITERIA: Known allergy to dexmedetomidine. Contraindications to dexmedetomidine (cardiac failure, cardiac arrhythmias, long QT syndrome, baseline bradycardia or hypotension, use of beta-blockers or digoxin, uncontrolled arterial hypertension, or recent stroke/intracranial bleeding). For the intranasal group only: children with URTI or nasal blockage within the preceding two weeks, as this alters mucosal drug absorption.
Intervention groups:
Two Groups.
Group A for Intranasal Rout
Group B for Intravenous rout
Main outcome variables:
Onset time
Duration
Recovery time
Study aim:
To compare the effects of low-frequency neuromuscular electrical stimulation (5 Hz) and percussive mechanical stimulation (50–60 Hz) on upper limb function and spasticity in post-stroke patients.
Design:
Randomized Clinical Trial (RCT) with two parallel intervention groups.
Settings and conduct:
The study will be conducted at Surraya Azeem (Waqf) Hospital, Lahore. Data will be collected from eligible post-stroke patients, who will be randomly allocated into two intervention groups and will receive the assigned intervention along with conventional treatment.
Participants/Inclusion and exclusion criteria:
Participants aged 40–70 years, of either sex, with a history of stroke for more than 4 months, Brunnstrom Recovery Stage 2–5, confirmed upper-limb spasticity with a Modified Tardieu Scale score >1, and an upper-limb Fugl-Meyer Assessment score of 1–50 will be included. Patients with an implanted electronic device (e.g., pacemaker), upper-limb fracture, traumatic brain injury, transient ischemic attack, severe cognitive impairment, or a history of epilepsy will be excluded.
Intervention groups:
Group A will receive low-frequency NMES at 5 Hz, applied to the upper-limb extensor muscle group. Group B will receive percussive mechanical stimulation at 50–60 Hz, also applied to the upper-limb extensor muscle group. Both groups will receive conventional treatment including ROM, strengthening, PNF patterns, and gait training.
Main outcome variables:
1. Upper limb spasticity — Modified Tardieu Scale (MTS)
2. Upper limb motor function — Fugl-Meyer Assessment (FMA)
3. Fine motor skills — Nine-Hole Peg Test (NHPT)
4. Gross motor skills — Box and Block Test (BBT)
5. Activities of daily living — Barthel Index
Study aim:
To evaluate the effect of levothyroxine on serum lipid profile in adults with subclinical hypothyroidism. LDL-C, total cholesterol, triglycerides and HDL-C will be assessed at baseline and 12 weeks.
Design:
Prospective, single-arm, interventional study conducted at the Department of Medicine, CMH Hyderabad. Participants will undergo baseline assessment before initiation of levothyroxine therapy and will be followed for 12 weeks with predefined clinical and laboratory assessments.
Settings and conduct:
Following approval from the Institutional Ethical Review Committee of CMH Hyderabad and prospective registration of the study, eligible participants will be recruited from the Department of Medicine. Participants will undergo baseline clinical assessment and laboratory investigations before initiation of treatment and will subsequently be assessed at predefined follow-up visits. Confidentiality and secure handling of participant data will be maintained according to institutional requirements.
Participants/Inclusion and exclusion criteria:
Adults aged 18–65 years with biochemically confirmed subclinical hypothyroidism who are eligible for levothyroxine. Exclude overt thyroid dysfunction, previous thyroid replacement therapy, pregnancy/lactation, and inability or unwillingness to comply with treatment and follow-up.
Intervention groups:
All enrolled patients received the same levothyroxine regimen of 1.6 mcg/kg/day.
Main outcome variables:
Primary outcome: change in serum LDL-C, total cholesterol, triglycerides and HDL-C from baseline to 12 weeks. Secondary outcomes: change in serum TSH and time to biochemical euthyroidism.
Study aim:
To compare neonatal outcomes following metformin-first versus insulin treatment of maternal gestational diabetes mellitus in a randomized controlled trial
Design:
Single center prospective open -label parallel group superiority RCT
Settings and conduct:
Maternal Fetal Medicine Department of Obstetrics and Gynaecology Lady Reading Hospital MTI Peshawar
Participants/Inclusion and exclusion criteria:
Women aged ≥18 years with a singleton viable pregnancy randomized at 24+0–33+6 weeks with GDM inadequately controlled after 7–14 days of lifestyle intervention and glucose monitoring, and providing written informed consent for neonatal assessment and follow-up
Pre-existing or overt diabetes HbA1c ≥6.5%urgent insulin requirement ketosis symptomatic hyperglycemia or fasting glucose 6.0–6.9 mmol/L with significant fetal overgrowth polyhydramnios current glucose lowering medication multiple pregnancy major fetal anomaly or growth restriction hypertension or preeclampsia imminent delivery significant hepatic renal disease acute kidney injury acidosis severe infection dehydration or relevant drug allergy inability to consent or complete follow-up or participation in another interventional trial
Intervention groups:
Metformin first treatment titared to tolerance and glucose response with prompt supplemental insulin
Main outcome variables:
Neonatal hypoglycemia blood glucose below the prespecified threshold within 48 hours of birth
Birth weight large forgestationalage macrosomia respiratory distress NICU admission preterm birth low birth weight Apgar scores 1 and 5 minutesand neonatal death
Percentage of fasting and 1hour postprandial glucose readings within targets maternal weight change insulin rescue and dose mode of delivery pre-eclampsia and adverse effects
Study aim:
To compare the frequency of antibiotic use within four weeks of enrollment among patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) managed using CRP point-of-care testing-guided antibiotic prescribing versus usual clinical care.
Design:
Single-center, two-arm, open-label, parallel-group randomized controlled trial involving 164 patients (82 per group), with 1:1 computer-generated randomization and four-week follow-up. No blinding will be performed.
Settings and conduct:
This open-label RCT will be conducted at Sheikh Zayed Hospital, Rahim Yar Khan. A total of 164 patients will be randomized into CRP-guided and usual-care groups, with follow-ups at weeks 1, 2, and 4. No blinding will be performed.
Participants/Inclusion and exclusion criteria:
Inclusion criteria:
Patients aged 40–60 years.
Both male and female patients.
Patients with a previous clinical diagnosis of COPD presenting with acute exacerbation according to the study's operational definition.
Exclusion criteria:
Pregnant women.
Antibiotic use within the preceding 5 days.
Patients with malignancy.
Patients unable or unwilling to provide informed consent or comply with the study protocol.
Patients currently participating in or recently enrolled in another research study.
Intervention groups:
Patients will be randomized into two groups. The intervention group will receive CRP-guided antibiotic management (CRP ≥20 mg/L), while the control group will receive usual clinical care. Both groups will be followed up at 1, 2, and 4 weeks to assess antibiotic use and clinical outcomes.
Main outcome variables:
The primary outcome measure is the proportion of patients receiving antibiotics within four weeks of enrollment, compared between the CRP-guided group and the usual-care group.
Study aim:
To determine the effects of clubbell and plyometric exercises on shoulder pain, range of motion and performance in bowlers
Design:
RANDOMIZED CONTROLLED TRIAL
Settings and conduct:
1. Pakistan Sports Board
2. Aleem Dar Cricket Academy
3. Shoaib Akhtar Cricket Academy
Participants/Inclusion and
Study aim:
The aim of the study is to find the compare the effects of electrical stimulation with and without motor re-learning programme on spasticity and upper limb function in stroke patients
Design:
Two arm parallel group randomized trial , single blind , of 62 stroke patients
Settings and conduct:
Sir Ganga Ram Hospital
Participants/Inclusion and exclusion criteria:
Inclusion criteria was as follows:
• Aged between 25-65 years
• Both Male and females
• Stroke Onset ≥3 months
• Ischemia Stroke
• Patients with limb spasticity equal to 2 or less than 2 on modified Ashworth scale
• Patients with English reading and writing skills
Exclusion Criteria:
• Patients with visual and auditory defects
• Patients with severe shoulder or wrist pain
• Patients with upper limb fractures/dislocations
• Contraindication to Electrical stimulation such as skin allergy
Intervention groups:
Both groups will receive electrical stimulation for 15 minutes with hot pack and the Stretching of muscles will be performed at the end. The sessions will be last 60 minutes five days a week for an 8-week period. Electrical stimulation will be used to stimulate flexion and extension of wrist and elbow. In Group A participants will receive electrical stimulation with motor relearning programme which consist of 4 steps as Step 1: Analysis of Task
Step 2: Practice of missing component
Step 3: Practice of Task
Step 4: Transference of training
In Group B Electrical stimulation without motor re-learning programme will be given. This protocol will be as including different exercises like Wrist flexion and extension, Finger flexion and extension, Forearm supination and pronation, tapping table top with all fingers, Opening of all fingers and Counting with fingers. These exercises which can be performed for 5-10 repetitions depending on patient's capacity.
Main outcome variables:
Spasticity
Upper limb function
neurological function
Study aim:
To evaluate the effectiveness of lower limb strength training and aerobic exercises in combination with lifestyle modification on strength, aerobic fitness and quality of life in patients with type II diabetes
Design:
Parallel group randomized clinical trial and Randomization will be achieved through computer generated random allocation software.
Settings and conduct:
District Head Quarter (DHQ) teaching Hospital Faisalabad, Tehsil Headquarter Hospital Gojra, AL Barkat Hospital Gojra, Hajra Tufail Hospital, Gojra. Patients and outcome assessor will be blinded. It will be assessor and participant who will be blinded about the type of intervention. Treatment will be given by principal /investigator.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Both male and female patients, Age: 40 to 60 years, Patient with diabetes type II diagnosed by physician
Exclusion criteria: Unsafe blood pressure, Mental retardation, Any recent surgery (cardiac, musculoskeletal and neurological) ,Fracture ,Limb amputation and joint replacement ,Central nervous system dysfunction (stroke, Parkinson disease)
Intervention groups:
The intervention group will include lower limb strength training, aerobic exercises, and a lifestyle modification program. Session duration will be 45 minutes, thrice a week, and 24 sessions over 8 weeks. The interventions of the control group will include lower limb strength training, aerobic exercises, and unguided lifestyle instructions. Session duration will be 45 minutes, thrice a week and 24 sessions over 8 weeks.
Main outcome variables:
Strength, Aerobic fitness, Quality of life
Study aim:
The aims are to compare the effectiveness of butler’s neural mobilization with SNAG mulligan’s mobilization to manage pain, disability and SLR ranges associated with subacute and chronic LBP
Design:
Single blind, parallel assigned, multicentered, randomized clinical trial will be conducted on 52 participants (2 groups with 26 each) with diagnosed LBP disc herniation
Settings and conduct:
Allied hospital and ProHealth rehab and medical center
Participants are kept anonymous for conducting the single blind trails
Participants/Inclusion and exclusion criteria:
Low back pain diagnosed with non-contained disc herniation with radiation to lower extremity of age 35-55 year of both genders, having pain from 6 weeks, patients who are not on analgesics, unilateral SLR is positive in between 35 and 70 degrees will be included.
Patients of cauda equina, saddle anesthesia, bowel and bladder symptoms, cancer, infection or inflammatory disease, bladder, kidney, uterus issues, injury, other severe medical or psychiatric illness pregnancy, history of any recent surgery, spinal surgery or artificial disc and LBP due to fracture, spine structural deformities like scoliosis, spinal fusion or osseous stenosis, patients on any other medical or therapeutic intervention within last 3 months, patient who are unable to participate in study due to any abnormality or refusal for consent will be excluded.
Intervention groups:
Group A: Baseline treatment will be TENS and hot pack, and then butler neural mobilization will be applied.
Group B: Baseline treatment will be same as group A and then SNAG mullligan mobilization will be applied.
Main outcome variables:
Low back pain and disability
Straight leg raise
Study aim:
To evaluate the combined effect of Kinesio tape and MWM on lateral ankle sprain.
Design:
Randomized clinical design
Settings and conduct:
The study will done on patients of the acute, the sub acute stage of grade I, II lateral ankle sprain and patients will selected from Al-Fateh Sports Complex Faisalabad and DHQ hospital Faisalabad.
participants after fullfilling the inclusion and exclusion creteria participants will selected for study and then divided into two groups.
Participants/Inclusion and exclusion criteria:
Inclusion criteria:
• Unilateral lateral ankle sprain, Grade II and grade I lateral ankle sprain (Kim, et al., 2018),Positive anterior drawer test (Kim, et al., 2018), Positive talar tilt test, Age of patient 15 to 30 years, Both male and female
(b) Exclusion criteria:
• Fracture in distal end of tibia and fibula (Kim, et al., 2018). Open wound at ankle joint (Hudson, et al., 2017). Sprain more than 72 hours.Patients having loss of ankle function by <5 degree (Shin, et al., 2020). Sensory loss at the ankle due to neurological issue (Kim, et al., 2018). Patients having skin diseases,Grade III ankle sprain.
Intervention groups:
. Then patients will randomly assigned in the two groups, Experimental group (group A) and the control (group B). The Experimental group receives 3 sets of 10 MWM repetitions in one treatment session and 30 sec of rest in each set and KT tapping 3 sessions a week for 4 weeks.
Control B received KT tapping 3 sessions a week for 4 weeks. Pre and Post intervention patients conditions will assess by the NRS, DPA- scale and the PSFS scale.
Main outcome variables:
NRS Numeric rating scale for pain. Patient specific functional scale (PSFS) for functional activity status.3 Disablement in physically active scale (DPA scale):This scale is used to gather data about disablement in four dimensions impairment,
Study aim:
To determine the effectiveness of low level laser therapy for treatment of cervical pain in patients with trigger point of upper trapezius muscle.
Design:
Single Blind , parallel , Randomized Controlled Trial
Settings and conduct:
This Randomized Controlled Trial ,Double Blind ,Parallel study will be conducted at University of Lahore Teaching Hospital
Participants/Inclusion and exclusion criteria:
Inclusion : Patients diagnosed with active upper trapezius trigger point.
•Both Male and female
•Age ranges from 18 to 55
Exclusion : Participants having contraindications for LASER e.g. Pregnancy, Tumors, Implants, Pacemaker,
•Past History of fracture of shoulder joint or cervical spine
•Whiplash injury
•Comorbid medical diagnosis e.g. osteoarthritis
•Psychiatric illness (e.g., schizophrenia or substance abuse)
•Irritable skin around the area of treatment
Intervention groups:
Patients of group-A will receive conventional physical therapy along with low level laser therapy ( LLLT with Omega Class IIIB Laser therapy unit with pen probe.)
While patients of group B, will receive conventional physical therapy only.
Main outcome variables:
Neck pain , Neck Range of Motion and Neck Disability Indexes
Study aim:
To determine the effects of gluteus medius muscle strengthening and lumbar stabilization exercise in chronic nonspecific low back pain with gluteus medius weakness.
Design:
A concealed, randomized, double-blinded, clinical trial with a parallel-group design of 18 patients
Settings and conduct:
Subjects from Madina University and Teaching Hospital, Faisalabad will be considered. Subjects and assessors are blinded.
Participants/Inclusion and exclusion criteria:
Inclusion
Females
Age 18 to 35 years
Having non-specific LBP, defined as pain anywhere from the inferior rib margin to the gluteal fold, for more than 3 months
Less than four out of five gluteus medius muscle strength on manual muscle testing
Numeric Pain Rating score 5 points or higher
Low back pain disability indices 20% or higher
Exclusion
A prior history of thoracolumbar or pelvis fracture
Thoracic, abdominal or lumbar spine surgery Radiculopathy, neurogenic claudication Primary or secondary spinal tumors
Pregnancy
Intervention groups:
Baseline treatment will be given to both groups with Infrared for 10 minutes. One group will receive Lumbar stabilization exercises and other group will receive gluteus medius strengthening protocol.
Main outcome variables:
The primary outcome will be self-reported pain. Secondary outcomes will be low back pain-related disability.
Study aim:
The study objective is to investigate the effectiveness of LLRPw-mHeath on physical disability and exercise adherence among knee osteoarthritis patients who are overweight and obese.
Design:
A parallel group, single blinded randomized control trial.
Sixty participants will be randomly divided into three groups by computer generated numbers.
It is a single centered.
Settings and conduct:
Study will be conducted at the Teaching Bay of Rehmatul-Lil-Alameene Post Graduate Institute of Cardiology. Participants are blinded in this study. Afetr randomization only one group will be called for their intervention in order to secure the blinding process.
Participants/Inclusion and exclusion criteria:
Inclusion criteria
Overweight and obese Knee OA patients; Both males and females; Aged between 45 to 60 years; Living in urban area of Punjab, Lahore.
Non-inclusion criteria: Rheumatoid arthritis; Flat feet; Spinal deformities; Surgery or injections of knee/s of any cause; System lupus erythematosus (SLE).
Intervention groups:
Intervention group 1 (LLRPw-mHeath): The researcher will teach the lower limb rehabilitation protocol by using mHealth and instructions of daily care and will advice them to carry out three times a week for 12-weeks at their houses. The researcher will send the reminder with the mHealth in the form of periodic manual WhatsApp messages two times a day for three days a week for 12 weeks.
Intervention group 2 (LLRPwo-mHealth): The researcher will teach the lower limb rehabilitation protocol and instructions of daily care and will advice them to carry out three times a week for 12-weeks at their houses.
Control group: The researcher will teach the instructions of daily care to the control group keeping in
mind the ethical consideration of patients.
Main outcome variables:
Physical disability; Exercise adherence
Study aim:
The purpose of this study is to assess and contrast how well Proprioceptive neuromuscular facilitation stretching and joint mobilization can enhance joint mobility and quality of life in individuals with knee osteoarthritis.
Design:
Randomised, superiority, parallel group trial with blinded outcome assessment on 48 participants. Randomisation was centralised and computerised with concealed randomisation sequence carried out at an external site
Settings and conduct:
A randomized, parallel-group, superiority trial with blinded outcome assessment. Participants (n=48) will be randomly assigned using a sealed envelope method into two intervention groups. This is a single-center study conducted at District Headquarter Hospital Bannu over a duration of four weeks.
Participants/Inclusion and exclusion criteria:
INCLUSION: Individuals aged between 40 to 75 years diagnosed with knee osteoarthritis based on clinical and radiographic criteria. Participants with a Kellgren-Lawrence grade II–III classification of knee OA.
EXCLUSION: OA patients who have received intra articular injections. Those with neurological disorders affecting lower limb function.
Intervention groups:
Control Group (Joint Mobilization - Group B)
Participants will receive Maitland joint mobilization (Grade III-IV), including anterior-posterior glides and patellar mobilization, to reduce stiffness and improve mobility. Sessions will be **three times per week for four weeks, progressing in intensity with weight-bearing mobilization.
Experimental Group (PNF Stretching - Group A)
Participants will undergo PNF stretching using the hold-relax technique for knee flexors and extensors, with progressive increases in hold duration and integration with functional movements. Sessions will be three times per week for four weeks.
Both groups will have a 5–10 minute warm-up and cool-down in each session.
Main outcome variables:
Quality of life